Effects of risperidone on auditory information processing in neuroleptic-naive patients with schizophrenia spectrum disorders

被引:0
|
作者
Korostenskaja, Milena
Dapsys, Kastysis
Siurkute, Aldona
Maciulis, Valentinas
Ruksenas, Osvaldas
Kahkonen, Seppo
机构
[1] Republican Vilnius Psychiat Hosp, Dept Electrophysiol, LT-11205 Vilnius, Lithuania
[2] Vilnius State Univ, Dept Biochem & Biophys, LT-03101 Vilnius, Lithuania
[3] Univ Helsinki, Cent Hosp, BioMag Lab, Helsinki 00029, Finland
[4] Univ Helsinki, Dept Psychol, Cognit Brain Res Unit, Helsinki 00014, Finland
[5] Vilnius Pedag Univ, Fac Pedag & Psychol, Dept Psychol, LT-08106 Vilnius, Lithuania
关键词
ERPs; P3; risperidone; schizophrenia;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Early effects of risperidone (2.5 +/- 1 mg/day) on auditory information processing were investigated in 9 neuroleptic naive patients with schizophrenia spectrum disorders and 9 healthy controls by using eventrelated potentials (ERPs). ERPs were elicited during active auditory "oddball" paradigm and were recorded before and after two weeks of treatment. Baseline P3 latencies were significantly delayed in patient group. Risperidone treatment did not change P3 amplitudes and latencies. However, P2 amplitudes were reduced in parallel with the clinical improvement measured by Positive and Negative Syndrome Scale (PANSS). Although risperidone did not change neural bases of active attention after two weeks of treatment, the reduction of P2 amplitude suggests that risperidone may affect auditory information processing in patients with schizophrenia spectrum disorders who never have been exposed to antipsychotic treatment.
引用
收藏
页码:139 / 144
页数:6
相关论文
共 50 条
  • [1] Movement disorders in neuroleptic-naive patients with schizophrenia spectrum disorders
    Ayehu, Moges
    Shibre, Teshome
    Milkias, Barkot
    Fekadu, Abebaw
    BMC PSYCHIATRY, 2014, 14
  • [2] Symptoms in neuroleptic-naive, first-episode schizophrenia: Response to risperidone
    Kopala, LC
    Fredrikson, D
    Good, KP
    Honer, WG
    BIOLOGICAL PSYCHIATRY, 1996, 39 (04) : 296 - 298
  • [3] Metabolomic Analysis of Biochemical Changes in the Plasma and Urine of First-Episode Neuroleptic-Naive Schizophrenia Patients after Treatment with Risperidone
    Cai, Hua-Lin
    Li, Huan-De
    Yan, Xian-Zhong
    Sun, Bo
    Zhang, Qi
    Yan, Miao
    Zhang, Wen-Yuan
    Jiang, Pei
    Zhu, Rong-Hua
    Liu, Yi-Ping
    Fang, Ping-Fei
    Xu, Ping
    Yuan, Hai-Yan
    Zhang, Xiang-Hui
    Hu, Li
    Yang, Wen
    Ye, Hai-Sen
    JOURNAL OF PROTEOME RESEARCH, 2012, 11 (08) : 4338 - 4350
  • [4] Patterns of symptoms in neuroleptic-naive patients with schizophrenia and related psychotic disorders before and after treatment
    Peralta, V
    Cuesta, MJ
    Martinez-Larrea, A
    Serrano, JF
    PSYCHIATRY RESEARCH, 2001, 105 (1-2) : 97 - 105
  • [5] Reduced volume of the cerebellar vermis in neuroleptic-naive schizophrenia
    Ichimiya, T
    Okubo, Y
    Suhara, T
    Sudo, Y
    BIOLOGICAL PSYCHIATRY, 2001, 49 (01) : 20 - 27
  • [6] Blunted serotonergic responsivity in neuroleptic-naive patients at first-episode of schizophrenia
    Reddy, Ravinder
    Keshavan, Matcheri
    Yao, Jeffrey K.
    SCHIZOPHRENIA RESEARCH, 2007, 90 (1-3) : 81 - 85
  • [7] Motor deficits and schizophrenia: the evidence from neuroleptic-naive patients and populations at risk
    Wolff, AL
    O'Driscoll, GA
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 1999, 24 (04): : 304 - 314
  • [8] Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia
    Hietala, J
    Syvälahti, E
    Vilkman, H
    Vuorio, K
    Räkköläinen, V
    Bergman, J
    Haaparanta, M
    Solin, O
    Kuoppamäki, M
    Eronen, E
    Ruotsalainen, U
    Salokangas, RKR
    SCHIZOPHRENIA RESEARCH, 1999, 35 (01) : 41 - 50
  • [9] Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia
    J K Yao
    G G Dougherty
    R D Reddy
    M S Keshavan
    D M Montrose
    W R Matson
    S Rozen
    R R Krishnan
    J McEvoy
    R Kaddurah-Daouk
    Molecular Psychiatry, 2010, 15 : 938 - 953
  • [10] APOMORPHINE EFFECTS ON BRAIN METABOLISM IN NEUROLEPTIC-NAIVE SCHIZOPHRENIC-PATIENTS
    CLEGHORN, JM
    SZECHTMAN, H
    GARNETT, ES
    NAHMIAS, C
    BROWN, GM
    KAPLAN, RD
    SZECHTMAN, B
    FRANCO, S
    PSYCHIATRY RESEARCH-NEUROIMAGING, 1991, 40 (02) : 135 - 153